"The Modified Pills-in-the-Pocket Strategy"

NARecruitingINTERVENTIONAL
Enrollment

328

Participants

Timeline

Start Date

October 23, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Atrial Fibrillation (AF)
Interventions
DRUG

use Amiodarone, Bisoprolol and Digoxin

"Amiodarone 200mg tid orally for 1 week, then reduced to 200mg bid orally for another week.~The dose of amiodarone will be reduced to 200mg bid orally for 1 week, and then 200mg qd maintenance treatment will be started in the 3rd week of dosing.~Bisoprolol 2.5-5mg qd oral treatment, the specific dose is decided by the investigator.~Digoxin 0.125mg qd orally."

Trial Locations (1)

Unknown

RECRUITING

Guangdong Provincial People's Hospital, Guangzhou

All Listed Sponsors
collaborator

Beijing Anzhen Hospital

OTHER

collaborator

Sir Run Run Shaw Hospital

OTHER

collaborator

First Affiliated Hospital, Sun Yat-Sen University

OTHER

collaborator

Nanfang Hospital, Southern Medical University

OTHER

collaborator

Zhongshan People's Hospital, Guangdong, China

OTHER

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

collaborator

Jiangmen Central Hospital

OTHER

collaborator

Xiamen Cardiovascular Hospital

UNKNOWN

collaborator

Yan 'an Hospital of Kunming City

UNKNOWN

lead

Yumei Xue

OTHER